SCHEMBL23167201

SCHEMBL23167201

Cc1nc2ccccc2n1Cc1ncc(C(=O)NO)cc1F

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 6/20 0.70
HDAC1 Q13547 5/20 0.70
HDAC3 O15379 2/20 0.70
HDAC4 P56524 2/20 0.70
HDAC7 Q8WUI4 2/20 0.70
HDAC2 Q92769 2/20 0.70
HDAC10 Q969S8 2/20 0.70
HDAC11 Q96DB2 2/20 0.70
HDAC8 Q9BY41 2/20 0.70
HDAC9 Q9UKV0 2/20 0.70
HDAC5 Q9UQL6 2/20 0.70
ADAM17 P78536 3/20 0.48
APAF1 O14727 1/20 0.45
TNF P01375 1/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GALR3 O60755 2/20 0.44
NR2F2 P24468 2/20 0.44
ALPL P05186 2/20 0.43
ALPG P10696 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29779589 1.00 HDAC6 (0.70) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL29779620 0.87 HDAC1 (0.56) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL23167351 0.87 HDAC1 (0.56) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL23202499 0.85 HDAC1 (0.52) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL23201965 0.85 HDAC6 (0.52) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL23201976 0.85 HDAC6 (0.52) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL22110373 0.83 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL23201962 0.83 HDAC1 (0.49) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL23167180 0.81 GALR3 (0.56) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL12850475 0.77 HDAC1 (1.00) HDAC6HDAC1HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230123856-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF TENAYA THERAPEUTICS, INC. (US) 2023-04-20 US disclosed
US-20230123856-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF TENAYA THERAPEUTICS, INC. (US) 2023-04-20 US disclosed
EP-4037670-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF Tenaya Therapeutics, Inc. (US) 2022-08-10 EP disclosed
WO-2021067859-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF TENAYA THERAPEUTICS, INC. (US) 2021-04-08 WO disclosed
WO-2021067859-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF TENAYA THERAPEUTICS, INC. (US) 2021-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230123856-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF SLC28A1, SLC5A1, SLC9A5 HDAC6 40/4885HDAC1 60/4885HDAC3 367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.